Common Equity: The sum of all common equity items.
COSCIENS Biopharma Inc. (T.CSC) had Common Equity of 14.57M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-5.25M |
|
-- |
|
-- |
|
-- |
|
-5.19M |
|
-- |
|
-5.25M |
|
-5.25M |
|
-5.25M |
|
-5.25M |
|
-5.25M |
|
-5.25M |
|
-5.19M |
|
-4.76M |
|
3.15M |
|
3.15M |
|
-1.67 |
|
-1.67 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
44.72M |
|
-- |
|
-- |
|
-- |
|
30.15M |
|
|
Common Equity |
14.57M |
14.57M |
|
14.57M |
|
3.15M |
|
| Cash Flow Statement Financials | |
-2.70M |
|
-0.88M |
|
-0.29M |
|
23.54M |
|
19.76M |
|
-3.78M |
|
0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.88 |
|
-- |
|
-- |
|
0.16 |
|
0.22 |
|
29.53% |
|
-241.13% |
|
-241.13% |
|
-- |
|
-243.67% |
|
-243.67% |
|
-3.58M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.43 |
|
0.81 |
|
111.54 |
|
-36.03% |
|
-36.03% |
|
-11.74% |
|
-30.16% |
|
4.63 |
|
-1.14 |
|
-0.86 |
|